Experience with treatment of osteoporosis with Ossin
Nemec, M.; Kovác, M.; Varga, G.; Nemec, P.
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 48(6): 557-561
1981
ISSN/ISBN: 0001-5415 PMID: 7324737 Document Number: 182577
Document emailed within 1 workday
Related Documents
Rico Lenza, H.; Espinós Pérez, D. 1982: Our experience in the treatment of post-menopausal osteoporosis Medicina Clinica 78(8): 322-325Rossini, M.; Di Munno, O.; Gatti, D.; Giannini, S.; Minisola, S.; Varenna, M.; Adami, S. 2011: Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience Clinical and Experimental Rheumatology 29(4): 728-735
Kocián, J. 1980: Experiences with Ossin Medicinski Pregled 33(7-8): 309-316
Grecomoro, G.; Martorana, U.; Muscolino, A. 1983: Our experience on the use of low-dose calcitonin in osteoporosis La Clinica Terapeutica 107(4): 297-303
Buffo, L.; Rossini, M.; Buoncristiano, A.; Girardello, S.; Zamberlan, N.; Diani, F.; Adami, S. 1996: Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate Minerva Ginecologica 48(6): 263-272
Eiken, P.A.; Langdahl, B.L.; Eiken, F.L.; Walter, S.; Poulsen, M.Hvid.; Abrahamsen, B. 2011: Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer Ugeskrift for Laeger 173(48): 3093-3096
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Syc, S. 1971: Causes of cortisol-induced osteoporosis and Cushing's disease osteoporosis Wiadomosci Lekarskie 24(1): 41-43
Halbekath, J. 2000: Drug treatment for the treatment of primary osteoporosis Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(6): 453-460
Villiaumey, J.; Hioco, D.; Larget-Piet, B. 1979: The treatment of osteoporosis Annales de Medecine Interne 130(3): 159-163
Uebelhart, B.; Rizzoli, R.é 2007: Osteoporosis treatment Revue Medicale Suisse 3(94): 150-153
Chang, S.Fang.; Yang, R.Sen. 2014: Determining the cut-off point of osteoporosis based on the osteoporosis self-assessment tool, body mass index and weight in Taiwanese young adult women Journal of clinical nursing 23(17-18): 2628-2635
Mizunuma, H. 2004: Treatment of osteoporosis with estrogen Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 397-403
Hagino, H. 2009: Risedronate for treatment of osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 67(5): 948-953